Asia-Pacific Liquid Biopsy Market By Cancer Type (Lung Cancer, Pancreatic Cancer, Leukemia And Other Visceral Cancers) By Sample Type (Blood, Urine, Plasma, Saliva And Cerebrospinal) By Diagnostic Approach (Circulating Tumour Cells (CTC), Circulating Tumour DNA (ctDNA), RNA In Exosomes And Extra-Cellular Vesicles), By End Users (Reference Laboratories, Hospital/Physician Laboratories, Academic And Research Centers, And Other End Users) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Asia-Pacific Liquid Biopsy Market By Cancer Type (Lung Cancer, Pancreatic Cancer, Leukemia And Other Visceral Cancers) By Sample Type (Blood, Urine, Plasma, Saliva And Cerebrospinal) By Diagnostic Approach (Circulating Tumour Cells (CTC), Circulating Tumour DNA (ctDNA), RNA In Exosomes And Extra-Cellular Vesicles), By End Users (Reference Laboratories, Hospital/Physician Laboratories, Academic And Research Centers, And Other End Users) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 953 | Pages: 145 | October 2018 | Region: Asia Pacific


The Asia-Pacific Liquid Biopsy market is expected to increase at a CAGR of 31.23% in the forecast period of 2018-2023 and reach a value of USD 681.12 million by 2023 from USD 175.01 million in 2018. The Asia-Pacific liquid biopsy market is projected to grow highest during the forecast period, primarily due to the increasing focus of players on this region. India and China are the Emerging countries in the Asia-Pacific region and expected to grow fast because of increased market access of each country’s population to healthcare resources. Asia-Pacific region is geographically segmented into China, India, Japan, Australia and South Korea.

Liquid biopsy is a technique which satisfies patients with the best treatment and also doctors by providing potential screening for disease. Molecular characterization of the tumour can also be done by liquid biopsy and it provides ease of repeat sampling for monitoring genetic changes as the procedure is non-invasive.

Medical communities are extending support for the market which is acting as a key driver. Liquid biopsy technique is under advancement and is continuously improving, which is helping drive its adoption in clinical applications. There are lot of new technologies coming up in the market such as for cell capturing, sample preparation and DNA amplification are making significant progress. Rise in technological competition is acting as a restraint for the market.

The liquid biopsy market is mainly segmented by types of cancer into Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers. By Diagnostic approach they can be classified as Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles. Based on end users, the market is segmented into reference laboratories, hospital/physician laboratories, academic and research centers, and other end users. The market is bifurcate into blood, urine, plasma, saliva and Cerebrospinal fluid based upon sample type. CTCs (Circulating Tumour cells), the first such entities on the liquid biopsy scene, have accounted for a large share in the market. Cancer institute is the largest end user segment in terms of revenues and is expected to create substantial opportunity in global liquid biopsy market over the forecast period.     

The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                           

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                              

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                            

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                     

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                      

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                      

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                               

5. Market Segmentation                                                                              

                5.1 By Cancer Type                                                         

                                5.1.1 Lung Cancer                                           

                                5.1.2 Pancreatic Cancer                                

                                5.1.3 Leukemia                                

                                5.1.4 Other Visceral Cancers                                       

                5.2 By Sample Type                                                        

                                5.2.1 Blood                                        

                                5.2.2 Urine                                         

                                5.2.3 Plasma                                      

                                5.2.4 Saliva                                         

                                5.2.5 Cerebrospinal                                        

                5.3 By Diagnostic Approach                                                        

                                5.3.1 Circulating Tumour cells (CTC)                                        

                                5.3.2 Circulating Tumour DNA (ctDNA)                                  

                                5.3.3 RNA in exosomes                                 

                                5.3.4 Extra-Cellular Vesicles                                        

                5.4 By End Users                                                             

                                5.4.1 Reference Laboratories                                     

                                5.4.2 Hospital/Physician Laboratories                                     

                                5.4.3 Academic and Research Centers                                    

                                5.4.4 Other End Users                                   

6. Geographical Analysis                                                                              

                6.3 Asia-Pacific                                                 

                                6.1 Introduction                                              

                                6.2 China                                            

                                6.3 India                                              

                                6.4 Japan                                            

                                6.5 South Korea                               

                                6.6 Australia                                      

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                      

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                               

                                7.2.5 Competitive Rivalry within the Industry                                      

8. Market Leaders' Analysis                                                                        

                8.1 Janssen Diagnostics                                                

                                8.1.1 Overview                                

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                            

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Qiagen                                                         

                8.3 Rarecells SAS                                                             

                8.4 Silicon Biosystems                                                   

                8.5 SRI International                                                      

                8.6 Myriad Genetics                                                      

                8.7 Natera                                                          

                8.8 Personal Genome Diagnostics                                                            

                8.9 Sysmex Inostics                                                        

                8.10 Trovagene                                                

                8.11 Exosome Diagnostics                                                           

                8.12 HansaBiomed OU                                                  

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                        

                9.3 Agreements, collaborations and Joint Ventures                                                          

                9.4 New Product Launches                                                          

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Liquid Biopsy Market By Region, From 2018-2023(USD Million)
  2. Asia-Pacific Liquid Biopsy Market By Cancer Type, From 2018-2023(USD Million)
  3. Asia-Pacific Lung Cancer Market By Region, From 2018-2023(USD Million)
  4. Asia-Pacific Pancreatic Cancer Market By Region, From 2018-2023(USD Million)
  5. Asia-Pacific Leukemia Market By Region, From 2018-2023(USD Million)
  6. Asia-Pacific Other Visceral Cancers Market By Region, From 2018-2023(USD Million)
  7. Asia-Pacific Liquid Biopsy Market By Sample Type, From 2018-2023(USD Million)
  8. Asia-Pacific Blood Market By Region, From 2018-2023(USD Million)
  9. Asia-Pacific Urine Market By Region, From 2018-2023(USD Million)
  10. Asia-Pacific Plasma Market By Region, From 2018-2023(USD Million)
  11. Asia-Pacific Saliva Market By Region, From 2018-2023(USD Million)
  12. Asia-Pacific Cerebrospinal Market By Region, From 2018-2023(USD Million)
  13. Asia-Pacific Liquid Biopsy Market By Diagnostic Approach, From 2018-2023(USD Million)
  14. Asia-Pacific Circulating Tumour cells (CTC) Market By Region, From 2018-2023(USD Million)
  15. Asia-Pacific Circulating Tumour DNA (ctDNA) Market By Region, From 2018-2023(USD Million)
  16. Asia-Pacific RNA in exosomes Market By Region, From 2018-2023(USD Million)
  17. Asia-Pacific Extra-Cellular Vesicles Market By Region, From 2018-2023(USD Million)
  18. Asia-Pacific Liquid Biopsy Market By End Users, From 2018-2023(USD Million)
  19. Asia-Pacific Reference Laboratories Market By Region, From 2018-2023(USD Million)
  20. Asia-Pacific Hospital/Physician Laboratories Market By Region, From 2018-2023(USD Million)
  21. Asia-Pacific Academic and Research Centers Market By Region, From 2018-2023(USD Million)
  22. Asia-Pacific Other End Users Market By Region, From 2018-2023(USD Million)
  23. China Liquid Biopsy Market By Cancer Type, From 2018-2023(USD Million)
  24. China Liquid Biopsy Market By Sample Type, From 2018-2023(USD Million)
  25. China Liquid Biopsy Market By Diagnostic Approach, From 2018-2023(USD Million)
  26. China Liquid Biopsy Market By End Users, From 2018-2023(USD Million)
  27. India Liquid Biopsy Market By Cancer Type, From 2018-2023(USD Million)
  28. India Liquid Biopsy Market By Sample Type, From 2018-2023(USD Million)
  29. India Liquid Biopsy Market By Diagnostic Approach, From 2018-2023(USD Million)
  30. India Liquid Biopsy Market By End Users, From 2018-2023(USD Million)
  31. Japan Liquid Biopsy Market By Cancer Type, From 2018-2023(USD Million)
  32. Japan Liquid Biopsy Market By Sample Type, From 2018-2023(USD Million)
  33. Japan Liquid Biopsy Market By Diagnostic Approach, From 2018-2023(USD Million)
  34. Japan Liquid Biopsy Market By End Users, From 2018-2023(USD Million)
  35. South Korea Liquid Biopsy Market By Cancer Type, From 2018-2023(USD Million)
  36. South Korea Liquid Biopsy Market By Sample Type, From 2018-2023(USD Million)
  37. South Korea Liquid Biopsy Market By Diagnostic Approach, From 2018-2023(USD Million)
  38. South Korea Liquid Biopsy Market By End Users, From 2018-2023(USD Million)
  39. Australia Liquid Biopsy Market By Cancer Type, From 2018-2023(USD Million)
  40. Australia Liquid Biopsy Market By Sample Type, From 2018-2023(USD Million)
  41. Australia Liquid Biopsy Market By Diagnostic Approach, From 2018-2023(USD Million)
  42. Australia Liquid Biopsy Market By End Users, From 2018-2023(USD Million)
Middle East And Africa Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Ov...
Latin America Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive ...
Asia-pacific Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive B...
Europe Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive Bladder...
North America Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive ...
Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive Bladder) And B...
Middle East And Africa Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Lab...
Latin America Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories...
Asia-Pacific Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories,...
Europe Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories, Refer...
North-America Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (Culture-based, PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospit...
Blood Culture Tests Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-202...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.